Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Prognosis of COVID-19 severity using DERGA, a novel machine learning algorithm
Panagiotis Asteris, Amir Gandomi, Danial Jahed Armaghani, Styliani Kokoris, Anastasia T Papandreadi, Anna Roumelioti, Stefanos Papanikolaou, Markos Z. Tsoukalas, Leonidas Triantafyllidis, Evangelos I. Koutras, Abidhan Bardhan, Ahmed Salih Mohammed, Hosein Naderpour, Satish Paudel, Pijush Samui, Ioannis Ntanasis‐Stathopoulos, Meletios Α. Dimopoulos, Evangelos Terpos (2024). Prognosis of COVID-19 severity using DERGA, a novel machine learning algorithm. European Journal of Internal Medicine, 125, pp. 67-73, DOI: 10.1016/j.ejim.2024.02.037.
Article411 days agoAssociation between problematic internet use, socio-demographic variables and obesity among European adolescents
Άρτεμις Τσίτσικα, Elisabeth K. Andrie, Θεοδώρα Ψαλτοπούλου, Chara K. Tzavara, Theodoros Ν. Sergentanis, Ioannis Ntanasis‐Stathopoulos, Flora Bacopoulou, Clive Richardson, George Chrousos, Μαρία Τσολιά (2016). Association between problematic internet use, socio-demographic variables and obesity among European adolescents. , 26(4), DOI: https://doi.org/10.1093/eurpub/ckw028.
Article316 days agoBelantamab Mafodotin plus Lenalidomide/Dexamethasone in Newly Diagnosed Patients with Multiple Myeloma: Long-Term Efficacy and Safety Results from the Phase 1/2 BelaRd Study
Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Nikolaos Kanellias, Eirini Solia, Panagiotis Malandrakis, Vasiliki Spiliopoulou, Foteini Theodorakakou, Magdalini Migkou, Evangelos Eleutherakis Papaiakovou, Despina Fotiou, Giorgos Psarros, Efstathios Kastritis, Meletios A Dimopoulos (2025). Belantamab Mafodotin plus Lenalidomide/Dexamethasone in Newly Diagnosed Patients with Multiple Myeloma: Long-Term Efficacy and Safety Results from the Phase 1/2 BelaRd Study. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)03784-x.
Article49 days agoMM-434: Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies
Konstantinos Giannakas, Panagiotis Malandrakis, Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Eirini Solia, Foteini Theodorakakou, Vasiliki Spiliopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Kostantina Taouxi, Alexandra Papadimou, Christine‐Ivy Liacos, Maria Gavriatopoulou, Ourania Tsitsilonis, Evangelos Terpos, Efstathios Kastritis, Meletios A Dimopoulos (2025). MM-434: Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)02604-7.
Article49 days agoMonoclonal gammopathy of undetermined significance in patients with solid tumours: Effects of immune checkpoint inhibitors on the monoclonal protein
Αngeliki Andrikopoulou, Ioannis Ntanasis‐Stathopoulos, Nikoletta‐Aikaterini Kokkali, Αριστέα-Μαρία Παπανώτα, Magdalini Migkou, Panagiotis Malandrakis, Vasiliki Spiliopoulou, Michalis Liontos, Flora Zagouri, Μαρία Καπαρέλου, Alkistis Papatheodoridi, Evangelos Terpos, Efstathios Kastritis, Meletios A Dimopoulos, Maria Gavriatopoulou (2025). Monoclonal gammopathy of undetermined significance in patients with solid tumours: Effects of immune checkpoint inhibitors on the monoclonal protein. , 206(6), DOI: https://doi.org/10.1111/bjh.20143.
Article49 days ago